Metabolomic Prediction of Breast Cancer Treatment–Induced Neurologic and Metabolic Toxicities
Authors:
- Max PiffouxMPMax Piffoux
- Jérémie JacqueminJJJérémie Jacquemin
- Mélanie PétéraMPMélanie Pétéra
- Stéphanie DurandSDStéphanie Durand
- Angélique AbilaAAAngélique Abila
- Delphine CentenoDCDelphine Centeno
- Charlotte JolyCJCharlotte Joly
- Bernard LyanBLBernard Lyan
- Anne-Laure MartinAMAnne-Laure Martin
- Sibille EverhardSESibille Everhard
- Sandrine BoyaultSBSandrine Boyault
- Barbara PistilliBPBarbara Pistilli
- 6 August 2024
- journal article
- research article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 30 (20) , 4654-4666
Abstract
Purpose: Long-term treatment-related toxicities, such as neurologic and metabolic toxicities, are major issues in breast cancer. We investigated the interest of metabolomic profiling to predict toxicities. Experimental Design: Untargeted high-resolution metabolomic profiles of 992 patients with estrogen receptor (ER)+/HER2− breast cancer from the prospective CANTO cohort were acquired (n = 1935 metabolites). A residual-based modeling strategy with discovery and validation cohorts was used to benchmark machine learning algorithms, taking into account confounding variables. Results: Adaptive Least Absolute Shrinkage and Selection (adaptive LASSO) has a good predictive performance, has limited optimism bias, and allows the selection of metabolites of interest for future translational research. The addition of low-frequency metabolites and nonannotated metabolites increases the predictive power. Metabolomics adds extra performance to clinical variables to predict various neurologic and metabolic toxicity profiles. Conclusions: Untargeted high-resolution metabolomics allows better toxicity prediction by considering environmental exposure, metabolites linked to microbiota, and low-frequency metabolites.Keywords
All Related Versions
Funding Information
- National Research Agency (ANR-10-COHO-0004)
- RHU My Probe (ANR-17-RHUS-008)
This publication has 16 references indexed in Scilit:
- Serum metabolic traits reveal therapeutic toxicities and responses of neoadjuvant chemoradiotherapy in patients with rectal cancerNature Communications, 2022
- Metabolomic profiles predict individual multidisease outcomesNature Medicine, 2022
- Ultra-high-performance liquid chromatography high-resolution mass spectrometry variants for metabolomics researchNature Methods, 2021
- A Metabolomics Approach for Early Prediction of Vincristine-Induced Peripheral NeuropathyScientific Reports, 2020
- Metabolomic Profiles Associated with BMI, Waist Circumference, and Diabetes and Inflammation Biomarkers in WomenObesity, 2019
- Incidence and Survival Among Young Women With Stage I–III Breast Cancer: SEER 2000–2015JNCI Cancer Spectrum, 2019
- Targeted Metabolomic Profiling of Plasma and Survival in Heart Failure PatientsJACC: Heart Failure, 2017
- Emerging applications of metabolomics in drug discovery and precision medicineNature Reviews Drug Discovery, 2016
- Sharpening Precision Medicine by a Thorough Interrogation of Metabolic IndividualityComputational and Structural Biotechnology Journal, 2016
- Illuminating the dark matter in metabolomicsProceedings of the National Academy of Sciences, 2015